High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival
Glioblastoma (GBM), the most aggressive brain tumor, is associated with a median survival at diagnosis of 16–20 months and limited treatment options. The key hallmark of GBM is altered tumor metabolism and marked increase in the rate of glycolysis. Aerobic glycolysis along with elevated glucose cons...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021-12-01
|
| Collection: | Frontiers in Molecular Biosciences |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.752404/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|